Susquehanna International Group’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $980K | Buy |
361,542
+187,164
| +107% | +$507K | ﹤0.01% | 3282 |
|
|
2025
Q1 | $392K | Sell |
174,378
-217,212
| -55% | -$489K | ﹤0.01% | 4665 |
|
|
2024
Q4 | $1.37M | Buy |
391,590
+5,160
| +1% | +$18.1K | ﹤0.01% | 2515 |
|
|
2024
Q3 | $1.59M | Sell |
386,430
-453,834
| -54% | -$1.87M | ﹤0.01% | 2119 |
|
|
2024
Q2 | $3.02M | Sell |
840,264
-779,363
| -48% | -$2.81M | ﹤0.01% | 1372 |
|
|
2024
Q1 | $5.34M | Buy |
1,619,627
+1,443,999
| +822% | +$4.77M | ﹤0.01% | 982 |
|
|
2023
Q4 | $406K | Buy |
175,628
+72,358
| +70% | +$167K | ﹤0.01% | 4136 |
|
|
2023
Q3 | $133K | Buy |
+103,270
| New | +$133K | ﹤0.01% | 4792 |
|
|
2023
Q2 | – | Sell |
-43,089
| Closed | -$30.5K | – | 6177 |
|
|
2023
Q1 | $30.5K | Buy |
43,089
+29,989
| +229% | +$21.2K | ﹤0.01% | 5542 |
|
|
2022
Q4 | $9.83K | Sell |
13,100
-38,825
| -75% | -$29.1K | ﹤0.01% | 5482 |
|
|
2022
Q3 | $45K | Sell |
51,925
-15,154
| -23% | -$13.1K | ﹤0.01% | 5526 |
|
|
2022
Q2 | $75K | Buy |
+67,079
| New | +$75K | ﹤0.01% | 5122 |
|
|
2022
Q1 | – | Sell |
-61,937
| Closed | -$99K | – | 6241 |
|
|
2021
Q4 | $99K | Buy |
61,937
+23,355
| +61% | +$37.3K | ﹤0.01% | 5299 |
|
|
2021
Q3 | $93K | Buy |
38,582
+17,453
| +83% | +$42.1K | ﹤0.01% | 4993 |
|
|
2021
Q2 | $67K | Buy |
21,129
+5,175
| +32% | +$16.4K | ﹤0.01% | 5126 |
|
|
2021
Q1 | $54K | Buy |
+15,954
| New | +$54K | ﹤0.01% | 5049 |
|